Biogen

Finance Manager, Corporate Functions

Posted on: 18 Jan 2021

Cambridge, MA

Job Description

Job Description

The Manager, Accounting and Business Planning will be responsible for all aspects of Accounting and FP&A supporting corporate functions. The candidate would be viewed as a trusted business partner, providing decision support by challenging and enlightening the business as to financial impacts of their decisions.

Manager is expected to drive financial discipline in the organization and should deliver flawless and timely execution of all accounting close and control processes, with commitment to the highest standards of integrity and accuracy.

Specific responsibilities will include:

* Oversee and assist in all aspects of accounting and planning, including:
* Management reporting of monthly and quarterly results
* Lead budgeting, forecasting and long-range planning for respective functions
* Present results and highlight risks and opportunities to functional business partners to ensure informed decisions can be made about activities throughout the year.
* Provide finance insights to make best decisions for organization and for Biogen
* Drive efficiencies in processes and resource allocation across functions
* Partner with business stakeholders to ensure the accuracy and integrity of the business cases and financial records. Ensure any relevant business case issues are identified, discussed, resolved, and documented appropriately
* Drive continuous process improvement to strive for automation and improved accuracy wherever possible
* Oversee and assist in all aspects of accounting, including:
* Monthly, quarterly and annual close processes
* Adhoc projects within Finance Organization, including but not limited to audit remediation, training, tracking and process improvement

Qualifications

* Minimum 5 years relevant experience in Finance, accounting or audit.
* Distinctive quantitative, critical thinking and modeling skills
* Advanced experience with Excel and PowerPoint. Ideally, systems experience with ERP (e.g. Oracle, etc.) plus Business Intelligence tools such as Qlik, Tableau, etc.
* Strong combination of financial and analytical skills
* Strong oral, presentation and written communications and the ability to build productive working relationships with various levels, functions and teams
* Attention to detail, yet proven ability to maintain an 80/20 mindset
* High sense of urgency with the ability to meet tight deadlines while maintaining the flexibility to adapt to changing priorities
* Proven leadership and interpersonal skills the ability to collaborate well with others and work cross-functionally across the organization.
* Ability to work well in teams and to build organizational relationships across all levels of the organization.
* Strong analytic abilities and business acumen, including ability to tell an impactful story leveraging data, metrics, and visualization to establish recommendations and convey conclusions
* Decisive and accountable
* Comfort dealing with ambiguity and a fast-paced entrepreneurial environment
* BS/BA or University degree in Accounting, Finance, Economics, Business, or other relevant background.
* CPA would be advantageous in this role

Additional Information

The Manager, Accounting and Business Planning will be responsible for all aspects of Accounting and FP&A supporting corporate functions. The candidate would be viewed as a trusted business partner, providing decision support by challenging and enlightening the business as to financial impacts of their decisions.

Biogen

Cambridge, MA

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.

Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.

The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.